Company intelligence
Ascentage Pharma
A Leader in the Discovery and Development of First and Best-in-class Small Molecule Cancer Therapies.
Biotechnology Research
Suzhou, China, and Rockville, Maryland, United States, CN
198 employees
Founded 2009
1 public signals
About Ascentage Pharma
Ascentage Pharma is a global, integrated biopharmaceutical company engaged in discovering, developing and commercializing therapies to address global unmet medical needs primarily in hematological malignancies and is in the process of conducting more than 40 clinical trials in specific regions worldwide. Ascentage Pharma has been listed on the Main Board of the HKEX with the stock code 6855.HK since October 2019 and recently listed in NASDAQ in January 2025 under the stock code AAPG.
Verified activity
Signals from Ascentage Pharma
1 published signal